Final weight loss outcomes were not significantly affected by a slower titration schedule
For obesity alone, only about 13 states cover it under fee-for-service as of 2026
At $149/month for the self-pay Wegovy pill , its actually cheaper than several compounded options on this list, while giving you the added assurance that your medication has been through the full FDA review process for safety and effectiveness
Marso SP, Bain SC, Consoli A, et al
Lancet Diabetes Endocrinol 6(4):275286 Rossing P, Baeres FMM, Bakris G, Bosch-Traberg H, Gislum M, Gough SCL et al (2023) The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
It is classified as a triple incretin receptor agonist , meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors